Clinical effect of white matter network disruption related to amyloid and small vessel disease

Hee Jin Kim¹, Kiho Im¹, Hunki Kwon¹+18

• ¹From the Departments of Neurology (H.J.K., Y.J.K., N.-Y.J., E.-D.K., D.L.N., S.W.S.), Nuclear Medicine (Y.S.C., K.H.L.), and Radiology (S.T.K.), Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; Neuroscience Center (H.J.K., Y.J.K., N.-Y.J., E.-D.K., D.L.N., S.W.S.), Samsung Medical Center, Seoul, Korea; Division of Newborn Medicine (K.I.), Boston Children's Hospital, Harvard Medical School, Boston, MA; Department of Biomedical Engineering (H.K., J.-M.L.), Hanyang University, Seoul, Korea; Division of Preventive Medicine (C.K.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Departments of Preventive Medicine (C.K.) and Neurology (B.S.Y.), and Department of Neurology, Gangnam Severance Hospital (H.C.), Yonsei University College of Medicine, Seoul; Department of Neurology (Y.N.), Gachon University Gil Medical Center, Incheon; Ewha Womans University Mokdong Hospital (G.H.K.), Ewha Womans University School of Medicine, Seoul; Departments of Nuclear Medicine (J.S.K.) and Neurology (J.H.L.), University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea; Institute for Stroke and Dementia Research (M.E.), Ludwig-Maximilians-University, Munich, Germany; and Center for Imaging of Neurodegenerative Diseases (M.W.W.), University of California, San Francisco; Department of Clinical Research Design and Evaluation (D.L.N., S.W.S.), SAIHST, Sungkyunkwan University, Seoul, Korea.+1